Famy Care Ltd. was established in 1990 by the Taparia group with a very modest beginning but an extremely sharp focus on the women’s reproductive healthcare segment and a vision to improve the quality of women's health through research and innovation. Over the next three decades, Famy Care became a global leader in supplying a wide range of contraceptive pills, injectable and Intrauterine devices to be the world’s largest generic manufacturer of oral contraceptive pills. Customers in over 100 countries depended on Famy Care for quality products that met their specific requirements. With more than 15% of all women in the world who use oral contraceptive pills manufactured by them, Famy Care became the trusted name, not only by millions of consumers around the world but also by the gynaecologists and physicians.
In the year 2015, the Taparia Family entered into a transaction for the sale of its women’s healthcare business to Mylan Inc., USA, one of the top five generic pharmaceutical companies globally, for USD 800 million.
The family is now looking at building business platforms across various sectors including the Consumer, Healthcare and Pharmaceutical space.
The Taparia family has collaborated with Axar Pharmaceuticals Inc. (Co-founded by Indian American Scientist and having its own R&D lab in southern California) and set up an Joint Venture Company in Switzerland, with a focus to develop complex generic products across therapies and dosage forms to cater regulated market with emphasis on niche and high value products. A separate R&D is set up in India focusing on CDO work and to facilitate the above objective by Taparia group company Kenpack Pharma Ltd.
Also, the Taparia’s picked up a majority stake in Guardian Life care, https://www.guardian.in/, India’s largest pharmacy chain with around 70 stores across Delhi and national capital region (NCR) and other parts of India. Guardian also has India’s master franchisee for GNC, a leading neutraceutical brand from the USA.
In the consumer space, the Taparia family has acquired Hip Hop Brand (http://www.hiphopskincare.com/), a unique platform in the personal grooming industry with a niche and interesting product portfolio. The Group is excited about this opportunity and has built a vision to grow this platform and the brand to a level of close to INR 100Cr over the next five years.
The Taparia family members were the India's highest individual tax-payer during the assessment year 16-17. The family has a strong reputation and network in the healthcare and financial sectors.
The Group also has a large treasury. The Investment activity is being called through various entities, prominent among them is Famy Energy Private Limited. The core business of FEPL is commodity trading, Investment in Real estate, securities and Derivatives including Future & Options